VVelarionINTELLIGENCE
Sign inStart free trial
Start free trial
MedTech & Diagnostics

Stereotaxis Executive Compensation (FY25)

STXS · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
David Fischel
Latest say-on-pay support
=
May 14, 2026
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.

The Stereotaxis brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
Data as of October 27, 2026Latest filing (8-K): May 15, 2026
9 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Stereotaxis brief$1,500Get the executive brief
Velarion Intel, one year, every company
87 figures on this page: 81 cited to the filing that reported them, 6 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — David Fischel: $62,195 → $64,390

Frequently asked questions

Answers drawn from the data on this page.
Who is Stereotaxis' chief executive and what were they paid?
David Fischel, Chief Executive Officer, received $64,390 in total compensation for fiscal 2025. Compared with the $62,195 reported for fiscal 2024, Fischel's total was up.
What was Stereotaxis' say-on-pay result?
The say-on-pay proposal drew 98.2% support at the meeting held May 14, 2026 for fiscal 2025.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kimberly Peery
Chief Financial Officer
◇——◇◇—◇◇
David Fischel
Chief Executive Officer
◇—————◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kimberly Peery
Chief Financial Officer
◇——◇◇—◇◇
David Fischel
Chief Executive Officer
◇—————◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kimberly Peery
Chief Financial Officer
◇——◇◇—◇◇
David Fischel
Chief Executive Officer
◇—————◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kimberly Peery
Chief Financial Officer
◇——◇◇—◇◇
David Fischel
Chief Executive Officer
◇—————◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
David FischelRSU◇◇——
Option◇—◇2/26/2028
Kimberly PeeryOption◇—◇4/8/2035
Option◇—◇3/8/2031
Option◇—◇3/9/2030
Option◇—◇3/3/2029
Option◇—◇4/2/2034
Option◇—◇3/1/2033
Option◇—◇2/25/2032
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Nathan Fischel, M.D
—◇————◇
Ross Levin
—◇————◇
Nachum Shamir
—◇————◇
Myriam Curet
—◇————◇
Dr. Arun S. Menawat
—◇————◇
David W. Benfer
Lead independent director
—◇————◇
David L. Fischel served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board equity retainer◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 14, 2026=◇◇◇
2022May 18, 2023=◇◇◇
2019May 21, 2020=◇◇◇
2017May 22, 2018=◇◇◇
2016May 23, 2017=◇◇◇
2015May 24, 2016=◇◇◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- David Fischel (Chief Executive Officer), FY2025 total compensation $64,390 (base salary $60,000) [exec_comp, SEC accession 0001493152-26-015027, filed 2026-04-03]

See a complete sample report

Answered within 24 hours, every figure cited to its SEC filing. This is a one-off report: no refunds.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Stereotaxis files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Stereotaxis disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Stereotaxis' disclosed peer group is defensible, who names Stereotaxis back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
87 figures on this page: 81 cited to the filing that reported them, 6 calculated from figures it prints.
81 cited to the filing
6 calculated from the filing

Documents cited

  1. 0001493152-26-023654
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001493152-26-015027
    DIRECTOR COMPENSATION · Outstanding Equity Awards at Fiscal Year-End · Summary Compensation Table
  3. 0001641172-25-002746
    Summary Compensation Table
  4. 0001493152-24-013167
    Summary Compensation Table
  5. 0001493152-23-018391
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0001493152-20-009661
    Item 5.07 Submission of Matters to a Vote of Security Holders
  7. 0001193125-18-171487
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0001193125-17-184531
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0001193125-16-602389
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Stereotaxis executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/STXS (accessed 2026).
Short form: data: Velarion

The Stereotaxis brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
9 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Stereotaxis and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy